Biogen BIIB has outperformed the market over the past 15 years by 2.68% on an annualized basis producing an average annual return of 9.81%. Currently, Biogen has a market capitalization of $30.82 billion.
Buying $100 In BIIB: If an investor had bought $100 of BIIB stock 15 years ago, it would be worth $408.24 today based on a price of $212.42 for BIIB at the time of writing.
Biogen's Performance Over Last 15 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.